Developer docs
API playgroundTry for free, no card

Search company profiles

The Science Behind

Full company profile

uuid02lh72n

Namestring
The Science Behind
Legal namestring
Brainbox Ltd
Company typeenum
Private
Founded yearint
2016
Descriptiontext

The Science Behind is a Cardiff, UK-based specialist clinical research services provider focused on Phase I (early-phase) clinical trials for central nervous system (CNS) drug candidates. It operates as a trading division of Brainbox Ltd (registered in England and Wales, company number 07288205) and was established in 2016. Its core offer is a portfolio of non-invasive neurostimulation and neuroimaging service modules — Pharmaco-TMS (Transcranial Magnetic Stimulation including TMS-EDMs and Threshold Tracking Paired Pulse protocols), Pharmaco-EEG (32-channel qEEG with 10-20 electrode placement and auditory habituation paradigms), Cognitive and Physiological Assessments, and Quantitative Sensory Testing (static and dynamic somatosensory protocols such as temporal summation and conditioned pain modulation). These modalities are offered standalone or in integrated multimodal combinations, including TMS-EEG, to capture both motor and non-motor cortical regions and deliver objective, quantifiable pharmacodynamic readouts in early-phase CNS studies.

The firm delivers these services through a turnkey, study-by-study professional services model, supplying protocol design, equipment, trained EEG and TMS technicians, site training, data collection, quality control, and analysis, which removes the need for clients to make capital investment in specialised neuroscience infrastructure. Customers are CNS-focused pharmaceutical and biotechnology sponsors (e.g., Synendos Therapeutics on SYT-510; Autifony Therapeutics on AUT00201 in MEAK) and Contract Research Organisations (Richmond Pharmacology, Simbec-Orion), with additional academic drug-discovery engagement (Cardiff University's Medicines Discovery Institute on MDI-26478 for cognitive decline in schizophrenia). The company is ISO 9001:2015 and ISO 27001:2013 certified and draws on an extended consulting network of academic neuroscientists from Oxford, Bristol, Trinity College Dublin, King's College London, the University of Nottingham, and the University of Cagliari.

Revenue mechanics are split between two professional services streams — clinical research services sold to sponsors and CROs, and technical consultancy for IND-enabling and proof-of-concept trial design (biomarker strategy, dose optimization, population enrichment) — delivered via direct enterprise sales and amplified through content marketing (website blog/news), LinkedIn, technical webinars, and industry conferences such as Anglonordic Life Science Conference 2026. Pricing is quote-based and not publicly disclosed; no revenue, funding, or headcount growth figures are available in the public record.

Short descriptiontext

The Science Behind is a Cardiff-based specialist clinical research services provider that integrates non-invasive neurostimulation (TMS), EEG, and Quantitative Sensory Testing into Phase I CNS drug trials for biotech, pharma, and CRO clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCardiff, United Kingdom
HQ citystring
Cardiff
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, neurostimulation technologies, CNS drug development, Phase I trials, neuroimaging biomarkers
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAIALAE
Clinical Development (Phase I–III Trial Design & Execution)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Clinical Research Services (CNS / Neuroscience)
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Research Services
TypeProfessional Services
Description

Specialist neuroscience support services provided to pharmaceutical companies and CROs on a study-by-study basis. Services include protocol design, equipment provision, site training, data collection, quality control, and analysis for Phase I clinical trials. No capital investment required from clients.

thesciencebehind.com
2Technical Consultancy
TypeProfessional Services
Description

Expert consultancy services for clinical trial design, particularly for IND-enabling and proof-of-concept trials. Includes biomarker strategy, dose optimization, and population enrichment strategies.

thesciencebehind.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Science Behind provides specialist neuroscience clinical research services for early-phase (Phase I) CNS drug trials, integrating non-invasive neurostimulation (TMS), neuroimaging (EEG), cognitive and physiological assessments, and Quantitative Sensory Testing (QST) to deliver objective pharmacodynamic and target-engagement readouts. Offerings are delivered study-by-study and span protocol design, provision of specialized equipment, site staff training, on-study deployment, and centralized data analysis for pharmaceutical and biotech sponsors and CROs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • EEG biomarkers consistent with anxiolytic drug profiles demonstrated in Phase I trials
+1 more record
Product overview1 text field

The Science Behind is a specialist neuroscience services provider offering an integrated portfolio of non-invasive neurostimulation and neuroimaging solutions for Phase I clinical trials. The core offering comprises four interconnected service modules: Pharmaco-TMS (transcranial magnetic stimulation for cortical excitability assessment), Pharmaco-EEG (quantitative EEG for brain activity monitoring), Cognitive & Physiological Assessments (cognitive test batteries and physiological monitoring), and Quantitative Sensory Testing (standardised pain and sensory threshold evaluation). These multimodal solutions are designed to work independently or in combination, enabling clients to obtain objective measures of target engagement, dose response, and drug effect timing in early-phase CNS drug development.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierParent CompanyTypeOthers
Description

Brainbox Ltd is the parent company of The Science Behind. The Science Behind operates as a trading name of Brainbox Ltd, registered in England and Wales.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1IXICO
TypeDirect peer
Description

Specialist neuroimaging biomarker CRO serving CNS clinical trials including Alzheimer's and other neurological indications. Comparable to The Science Behind's neuroimaging-enabled Phase I support and similar asset-light deployment model.

TypeDirect peer
Description

France-headquartered early-phase CRO with strong CNS and neurology expertise. Competes for Phase I CNS trial work and offers similar EEG/TMS-adjacent capabilities to The Science Behind.

TypeDirect peer
Description

Early-phase CRO with strong neuroscience and biomarker capabilities including CNS trials. Directly comparable to The Science Behind's Phase I CNS service offering.

TypeBroad incumbent
Description

Mid-size global CRO with a dedicated CNS/neuroscience therapeutic area. Larger and broader than The Science Behind but competes for the same Phase I/II neuroscience trial work.

TypeDirect peer
Description

US-based CNS trial analytics company specializing in EEG-based biomarkers for clinical trials. Directly comparable to The Science Behind's Pharmaco-EEG offering and competing for the same CNS Phase I/II sponsor budgets.

TypeBroad incumbent
Description

Large clinical trial technology and biomarker company offering EEG, imaging, and digital endpoints across CNS trials. Overlaps with The Science Behind's CNS electrophysiology work as a much larger established player.

TypeDirect peer
Description

Provides EEG and cognitive biomarker platforms specifically for CNS clinical trials. Competes head-to-head with The Science Behind's Pharmaco-EEG and cognitive assessment services for sponsor and CRO clients.

TypeDirect peer
Description

UK-based Phase I clinical trial CRO — also an existing partner of The Science Behind. Directly competes for Phase I CNS work and represents both a customer and a comparable service provider.

TypeDirect peer
Description

Global early-phase clinical research CRO with CNS and neuroscience experience. Comparable service portfolio and target customers (biotech/CRO sponsors running Phase I studies).

TypeDirect peer
Description

Welsh-based early-phase clinical research CRO with a Phase I accredited unit — also an existing partner. Overlaps with The Science Behind on Phase I CNS trial delivery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Science Behind

Clinical Research Services (CNS / Neuroscience)thesciencebehind.com

The Science Behind is a Cardiff-based specialist clinical research services provider that integrates non-invasive neurostimulation (TMS), EEG, and Quantitative Sensory Testing into Phase I CNS drug trials for biotech, pharma, and CRO clients.

What The Science Behind does

The Science Behind is a Cardiff, UK-based specialist clinical research services provider focused on Phase I (early-phase) clinical trials for central nervous system (CNS) drug candidates. It operates as a trading division of Brainbox Ltd (registered in England and Wales, company number 07288205) and was established in 2016. Its core offer is a portfolio of non-invasive neurostimulation and neuroimaging service modules — Pharmaco-TMS (Transcranial Magnetic Stimulation including TMS-EDMs and Threshold Tracking Paired Pulse protocols), Pharmaco-EEG (32-channel qEEG with 10-20 electrode placement and auditory habituation paradigms), Cognitive and Physiological Assessments, and Quantitative Sensory Testing (static and dynamic somatosensory protocols such as temporal summation and conditioned pain modulation). These modalities are offered standalone or in integrated multimodal combinations, including TMS-EEG, to capture both motor and non-motor cortical regions and deliver objective, quantifiable pharmacodynamic readouts in early-phase CNS studies.

The firm delivers these services through a turnkey, study-by-study professional services model, supplying protocol design, equipment, trained EEG and TMS technicians, site training, data collection, quality control, and analysis, which removes the need for clients to make capital investment in specialised neuroscience infrastructure. Customers are CNS-focused pharmaceutical and biotechnology sponsors (e.g., Synendos Therapeutics on SYT-510; Autifony Therapeutics on AUT00201 in MEAK) and Contract Research Organisations (Richmond Pharmacology, Simbec-Orion), with additional academic drug-discovery engagement (Cardiff University's Medicines Discovery Institute on MDI-26478 for cognitive decline in schizophrenia). The company is ISO 9001:2015 and ISO 27001:2013 certified and draws on an extended consulting network of academic neuroscientists from Oxford, Bristol, Trinity College Dublin, King's College London, the University of Nottingham, and the University of Cagliari.

Revenue mechanics are split between two professional services streams — clinical research services sold to sponsors and CROs, and technical consultancy for IND-enabling and proof-of-concept trial design (biomarker strategy, dose optimization, population enrichment) — delivered via direct enterprise sales and amplified through content marketing (website blog/news), LinkedIn, technical webinars, and industry conferences such as Anglonordic Life Science Conference 2026. Pricing is quote-based and not publicly disclosed; no revenue, funding, or headcount growth figures are available in the public record.

The Science Behind firmographics

Firmographics
Name
The Science Behind
Legal name
Brainbox Ltd
Website
https://thesciencebehind.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
The Science Behind is a Cardiff-based specialist clinical research services provider that integrates non-invasive neurostimulation (TMS), EEG, and Quantitative Sensory Testing into Phase I CNS drug trials for biotech, pharma, and CRO clients.
Ownership category
akta.pro rank

The Science Behind industry classification

Industry
Product category
Clinical Research Services (CNS / Neuroscience)
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAIALAE
Clinical Development (Phase I–III Trial Design & Execution)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Clinical research services
  • Neurostimulation technologies
  • CNS drug development
  • Phase I trials
  • Neuroimaging biomarkers

Where The Science Behind is headquartered

Location

Headquarters

HQ city
Cardiff
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

The Science Behind business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Clinical Research Services: Specialist neuroscience support services provided to pharmaceutical companies and CROs on a study-by-study basis. Services include protocol design, equipment provision, site training, data collection, quality control, and analysis for Phase I clinical trials. No capital investment required from clients.
  2. Technical Consultancy: Expert consultancy services for clinical trial design, particularly for IND-enabling and proof-of-concept trials. Includes biomarker strategy, dose optimization, and population enrichment strategies.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

The Science Behind product offering

Product offering

Core offering

The Science Behind provides specialist neuroscience clinical research services for early-phase (Phase I) CNS drug trials, integrating non-invasive neurostimulation (TMS), neuroimaging (EEG), cognitive and physiological assessments, and Quantitative Sensory Testing (QST) to deliver objective pharmacodynamic and target-engagement readouts. Offerings are delivered study-by-study and span protocol design, provision of specialized equipment, site staff training, on-study deployment, and centralized data analysis for pharmaceutical and biotech sponsors and CROs.

Product overview

The Science Behind is a specialist neuroscience services provider offering an integrated portfolio of non-invasive neurostimulation and neuroimaging solutions for Phase I clinical trials. The core offering comprises four interconnected service modules: Pharmaco-TMS (transcranial magnetic stimulation for cortical excitability assessment), Pharmaco-EEG (quantitative EEG for brain activity monitoring), Cognitive & Physiological Assessments (cognitive test batteries and physiological monitoring), and Quantitative Sensory Testing (standardised pain and sensory threshold evaluation). These multimodal solutions are designed to work independently or in combination, enabling clients to obtain objective measures of target engagement, dose response, and drug effect timing in early-phase CNS drug development.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • EEG biomarkers consistent with anxiolytic drug profiles demonstrated in Phase I trials
  • +1 more outcomes

Companies that use The Science Behind

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

The Science Behind technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

The Science Behind partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Brainbox Ltdparent companyOthersBrainbox Ltd is the parent company of The Science Behind. The Science Behind operates as a trading name of Brainbox Ltd, registered in England and Wales.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

The Science Behind competitors and assessment

Company assessment

Direct peers

  • IXICO: Specialist neuroimaging biomarker CRO serving CNS clinical trials including Alzheimer's and other neurological indications. Comparable to The Science Behind's neuroimaging-enabled Phase I support and similar asset-light deployment model.
  • Biotrial: France-headquartered early-phase CRO with strong CNS and neurology expertise. Competes for Phase I CNS trial work and offers similar EEG/TMS-adjacent capabilities to The Science Behind.
  • QPS Holdings: Early-phase CRO with strong neuroscience and biomarker capabilities including CNS trials. Directly comparable to The Science Behind's Phase I CNS service offering.
  • Beacon Biosignals: US-based CNS trial analytics company specializing in EEG-based biomarkers for clinical trials. Directly comparable to The Science Behind's Pharmaco-EEG offering and competing for the same CNS Phase I/II sponsor budgets.
  • Cumulus Neuroscience: Provides EEG and cognitive biomarker platforms specifically for CNS clinical trials. Competes head-to-head with The Science Behind's Pharmaco-EEG and cognitive assessment services for sponsor and CRO clients.
  • Richmond Pharmacology: UK-based Phase I clinical trial CRO — also an existing partner of The Science Behind. Directly competes for Phase I CNS work and represents both a customer and a comparable service provider.
  • Celerion: Global early-phase clinical research CRO with CNS and neuroscience experience. Comparable service portfolio and target customers (biotech/CRO sponsors running Phase I studies).
  • Simbec-Orion: Welsh-based early-phase clinical research CRO with a Phase I accredited unit — also an existing partner. Overlaps with The Science Behind on Phase I CNS trial delivery.

Broad incumbents

  • Worldwide Clinical Trials: Mid-size global CRO with a dedicated CNS/neuroscience therapeutic area. Larger and broader than The Science Behind but competes for the same Phase I/II neuroscience trial work.
  • Clario: Large clinical trial technology and biomarker company offering EEG, imaging, and digital endpoints across CNS trials. Overlaps with The Science Behind's CNS electrophysiology work as a much larger established player.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

The Science Behind social profiles

Digital presence

The Science Behind compliance and trust

Trust signal

Compliance2 records

The Science Behind financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Science Behind leadership team

Management profile

Number of profiles

Profiles7 records

The Science Behind funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Science Behind M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Science Behind

What does The Science Behind do?

The Science Behind provides specialist neuroscience clinical research services for early-phase (Phase I) CNS drug trials, integrating non-invasive neurostimulation (TMS), neuroimaging (EEG), cognitive and physiological assessments, and Quantitative Sensory Testing (QST) to deliver objective pharmacodynamic and target-engagement readouts. Offerings are delivered study-by-study and span protocol design, provision of specialized equipment, site staff training, on-study deployment, and centralized data analysis for pharmaceutical and biotech sponsors and CROs.

Is The Science Behind a public or private company?

The Science Behind is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was The Science Behind founded?

The Science Behind was founded in 2016. It employs 1 to 10 people.

Where is The Science Behind based?

The Science Behind is headquartered in Cardiff, United Kingdom, in the Europe region.

How does The Science Behind make money?

Two revenue lines are on record. Clinical Research Services are the primary driver. The others are technical Consultancy.

Who are The Science Behind's main competitors?

Direct peers on record are IXICO, Biotrial, QPS Holdings, Beacon Biosignals, Cumulus Neuroscience, Richmond Pharmacology, Celerion and Simbec-Orion. Broad incumbents are Worldwide Clinical Trials and Clario.

Does The Science Behind have an API?

No public API is recorded for The Science Behind.

What industry is The Science Behind in?

The Science Behind's product category is Clinical Research Services (CNS / Neuroscience). Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales